CAR T Cell Therapy for Relapsed/Advanced B-cell Lymphoma and Multiple Myeloma

CAR T Cell Therapy for Relapsed/Advanced B-cell Lymphoma and Multiple Myeloma

Dr. Andrew Branagan, from Massachusetts General Hospital (MGH) in Boston, USA, will discuss CAR T cell therapy for relapsed/advanced B-cell lymphoma and multiple myeloma. He will share insights into the innovative CAR T cell therapy approach, its applications, and outcomes in treating these hematological malignancies. Dr. Branagan's expertise promises to provide valuable information on this cutting-edge therapy and its potential impact on patient care.